MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin Sep 25 • 4 min read Mind Medicine (MindMed) Inc. announced that they have been conducting R&D work on psilocybin in collaboration with the University Hospital Basel’s Liechti Lab.
Havn Life Sciences submits range of natural health products to Health Canada Sep 24 • 2 min read Havn Life Sciences Inc. announced that it has submitted formulations for its natural health products to Health Canada.
COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares Sep 23 • 5 min read COMPASS Pathways plc announced the closing of its previously announced initial public offering American Depositary Shares.
Ehave, Inc. Launches Premier Psychedelic Retreat Centers Partnership and MyLifeID Card Giveaway Sep 22 • 8 min read Ehave, Inc. announced plans to offer access to premier psilocybin-guided wellness retreats through its subsidiary, Mycotopia Therapy.
MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor Sep 21 • 5 min read Mind Medicine (MindMed) Inc. is looking to expand its US investor base through an up-listing on the NASDAQ.